33 results for "Gregory Piazza"
Showing 1–20 · 0.91 seconds · RSS
-
Journal Article
Barriers to stroke prevention in Atrial Fibrillation: Insights from the global anticoagulation Roundtable
Atrial fibrillation (AF) accounts for one-quarter of the global ischemic stroke burden. Population growth and an increasing prevalence of stroke risk factors underscores the critical need to recognize and address the worldwide crisis in underutilization of antithrombotic therapy for patients with…
-
Journal Article Full text
Arterial Thrombotic Complications in COVID-19: A Case of Renal Infarction
COVID-19 infection has been associated with thrombotic complications, especially venous thromboembolism. Although arterial thrombotic complications are rarely seen in these patients, we report the case of a 43-year-old patient who developed thrombosis of the main branch of the left renal artery…
-
Journal Article
The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents
SARS-CoV-2 infection (COVID-19) results in local and systemic activation of inflammation and coagulation. In this review article, we will discuss the potential role of coagulation factor Xa (FXa) in the pathophysiology of COVID-19. FXa, a serine protease, has been shown to play a role in the…
-
Journal Article
Direct oral anticoagulants in cancer-associated venous thromboembolism: trial robustness and clinical trade-offs
Background: Although direct oral anticoagulants (DOACs) are often favored over low-molecular-weight heparin for cancer-associated thrombosis, the robustness of trial evidence supporting their use remains uncertain. Objectives: We evaluated the efficacy, safety, and statistical robustness of DOACs…
-
Journal Article
Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis
Background Extended duration thromboprophylaxis (ET) for approximately 30 days can effectively and safely reduce venous thromboembolism (VTE) risk in appropriately selected medically ill patients. We sought to estimate the proportion of hospitalized medically ill patients potentially qualifying for…
-
Journal Article
Trends in Bicuspid Aortic Valve–Attributable Death in the United States From 2010 to 2020
Background Population‐based data on bicuspid aortic valve (BAV)‐attributable mortality trends in the United States are limited. This study assessed trends in BAV‐attributable death in the United States from 2010 to 2020, evaluating differences by sex, ethnicity, urbanization, and census region…
-
Journal Article
Cardiovascular Risk in Young Patients Diagnosed With Obstructive Sleep Apnea
Background In older adults, obstructive sleep apnea (OSA) has been associated with several cardiovascular complications. Whether young patients diagnosed with OSA also are at higher risk of developing subsequent cardiovascular disease is uncertain. We aimed to estimate the risk of developing an…
-
Journal Article
Extended Anticoagulation After Pulmonary Embolism: A Multicenter Observational Cohort Analysis
Background Pulmonary embolism (PE) has a long‐term risk of adverse events, which can be prevented by extended anticoagulation. We compared clinical characteristics and outcomes between patients treated with 2‐year extended anticoagulation and those who were not, in a population who had completed an…
-
Journal Article
Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation
Abstract Atrial fibrillation (AF) is associated with an increased rate of mortality, heart failure, and stroke. We conducted an observational study to assess the relationship between anticoagulation and adverse clinical outcomes in hospitalized patients with AF. We performed a…
-
Journal Article
Risk of Recurrent Venous Thromboembolism in Selected Subgroups of Men: A Danish Nationwide Cohort Study
Background Although men are considered at high risk for recurrent venous thromboembolism (VTE), sex-specific data on prognostic factors are lacking. We estimated the cumulative recurrence risks associated with clinical characteristics and comorbidities known or suspected to be associated with the…
-
Journal Article
Value‐Based Medicine in the Management of Abdominal Aortic Aneurysms
The implementation of value‐based medicine reflects a transformation from volume incentivized care to a quality‐of‐care directed reimbursement model. Value‐based medicine aims to concurrently improve health care quality and control growing health care expenditures by aligning evidence‐based and…
-
Journal Article
β-Blockers after myocardial infarction with preserved or mildly reduced left ventricular ejection fraction: Fragility of contemporary evidence
Background: β-Blockers have been traditionally prescribed after acute myocardial infarction (MI), but contemporary evidence in patients with preserved or mildly reduced left ventricular ejection fraction (LVEF ≥40%) have not provided consistent results. We assessed the robustness of the evidence…
-
Journal Article
Trends in Sudden Cardiac Death Among Adults Aged 25 to 44 Years in the United States: An Analysis of 2 Large US Databases
Background Sudden cardiac death (SCD) in early adults aged 25 to 44 years represents an important and unexpected cause of death. We assessed trends in SCD‐related mortality in the United States from 1999 to 2020 among early adults to determine differences by sex, ethnoracial groups, urbanization…
-
Journal Article Full text
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19
BACKGROUND: Cardiovascular complications, including myocardial infarction, ischemic stroke, and pulmonary embolism, represent an important source of adverse outcomes in coronavirus disease-2019 (COVID-19). OBJECTIVES: To assess the frequency of arterial and venous thromboembolic disease, risk…
-
Journal Article
Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19
Severe acute respiratory syndrome coronavirus 2 infection (COVID-19) is known to induce severe inflammation and activation of the coagulation system, resulting in a prothrombotic state. Although inflammatory conditions and organ-specific diseases have been shown to be strong determinants of…
-
Journal Article
Cardiovascular-Kidney-Metabolic Syndrome-Attributable Mortality in the United States, From 2010 to 2023
Background: Cardiovascular-kidney-metabolic syndrome (CKM) is increasingly prevalent in the United States, yet long-term nationwide data on CKM-attributable mortality remain limited. Objectives: This study analyzed CKM-attributable mortality trends in the United States from 2010 to 2019, focusing…
-
Journal Article
Effectiveness and safety of rivaroxaban vs warfarin in patients with pulmonary embolism and right ventricular dysfunction: a retrospective cohort study
Background: Limited data exist comparing the effectiveness and safety of rivaroxaban and warfarin in patients with right ventricular dysfunction (RVD), a common acute pulmonary embolism (PE) complication. Objectives: To assess the effectiveness and safety of rivaroxaban compared with warfarin among…